SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-21-046879
Filing Date
2021-09-07
Accepted
2021-09-07 16:13:53
Documents
5

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea143938-s3_inmunebioinc.htm S-3 176237
2 OPINION OF SICHENZIA ROSS FERENCE LLP ea143938ex5-1_inmunebio.htm EX-5.1 9131
3 CONSENT OF MARCUM LLP ea143938ex23-1_inmunebio.htm EX-23.1 2275
4 GRAPHIC ex5-1_001.jpg GRAPHIC 15130
5 GRAPHIC ex5-1_002.jpg GRAPHIC 6209
  Complete submission text file 0001213900-21-046879.txt   218297
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-259368 | Film No.: 211239499
SIC: 2836 Biological Products, (No Diagnostic Substances)